BR112014001336A2 - formulações que contém saccharomyces boulardii e superóxido dismutase (sod) para controle da obseidade - Google Patents

formulações que contém saccharomyces boulardii e superóxido dismutase (sod) para controle da obseidade

Info

Publication number
BR112014001336A2
BR112014001336A2 BR112014001336A BR112014001336A BR112014001336A2 BR 112014001336 A2 BR112014001336 A2 BR 112014001336A2 BR 112014001336 A BR112014001336 A BR 112014001336A BR 112014001336 A BR112014001336 A BR 112014001336A BR 112014001336 A2 BR112014001336 A2 BR 112014001336A2
Authority
BR
Brazil
Prior art keywords
sod
formulations containing
superoxide dismutase
saccharomyces boulardii
obesity control
Prior art date
Application number
BR112014001336A
Other languages
English (en)
Inventor
Castagliuolo Ignazio
Busiello Immacolata
Miraglia Niccolò
Brun Paola
Original Assignee
Gnosis Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gnosis Spa filed Critical Gnosis Spa
Publication of BR112014001336A2 publication Critical patent/BR112014001336A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BR112014001336A 2011-08-03 2012-08-02 formulações que contém saccharomyces boulardii e superóxido dismutase (sod) para controle da obseidade BR112014001336A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001488A ITMI20111488A1 (it) 2011-08-03 2011-08-03 Formulazioni comprendenti saccharomyces boulardii e superossido dismutasi (sod) per controllare l'obesita'
PCT/EP2012/065119 WO2013017650A2 (en) 2011-08-03 2012-08-02 Formulations containing saccharomyces boulardii and superoxide dismutase (sod) to control obesity

Publications (1)

Publication Number Publication Date
BR112014001336A2 true BR112014001336A2 (pt) 2017-07-04

Family

ID=44675697

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014001336A BR112014001336A2 (pt) 2011-08-03 2012-08-02 formulações que contém saccharomyces boulardii e superóxido dismutase (sod) para controle da obseidade

Country Status (25)

Country Link
US (1) US9555082B2 (pt)
EP (1) EP2739295B1 (pt)
JP (1) JP6126595B2 (pt)
KR (1) KR101954674B1 (pt)
CN (1) CN103764156A (pt)
AU (1) AU2012292029B2 (pt)
BR (1) BR112014001336A2 (pt)
CA (1) CA2843794C (pt)
CY (1) CY1117187T1 (pt)
DK (1) DK2739295T3 (pt)
ES (1) ES2562647T3 (pt)
GE (1) GEP20166436B (pt)
HR (1) HRP20160293T1 (pt)
HU (1) HUE027121T2 (pt)
IL (1) IL230723B (pt)
IT (1) ITMI20111488A1 (pt)
MX (1) MX349242B (pt)
PL (1) PL2739295T3 (pt)
RS (1) RS54594B1 (pt)
RU (1) RU2600843C2 (pt)
SI (1) SI2739295T1 (pt)
SM (1) SMT201600086B (pt)
UA (1) UA112990C2 (pt)
WO (1) WO2013017650A2 (pt)
ZA (1) ZA201400758B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2870969A1 (fr) * 2013-11-08 2015-05-13 Biocodex Composition pharmaceutique pour la réduction de la masse adipeuse
KR101893735B1 (ko) * 2018-05-04 2018-08-31 주식회사이-글벳 열 안정성이 강화된 효모를 이용한 정장효능이 있는 산제 동물용 의약품 조성물 및 그 제조 방법
WO2024002150A1 (en) * 2022-06-29 2024-01-04 Microbiota I - Center (Magic) Limited Methods and compositions for treating obesity using microorganisms

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62215532A (ja) * 1986-03-18 1987-09-22 Ube Ind Ltd 抗炎症剤
FR2825004B1 (fr) * 2001-05-22 2005-02-11 Bio Springer Produit dietetique satiant
US20060008511A1 (en) * 2004-07-08 2006-01-12 Jhy-Jhu Lin Probiotic products for pet applications
US7935334B2 (en) * 2005-07-07 2011-05-03 Imagilin Technologies, LLC Probiotics as alternative medicines against infectious diseases
US20060093592A1 (en) * 2004-10-04 2006-05-04 Nutracea Synbiotics
SE529185C2 (sv) 2005-10-07 2007-05-22 Arla Foods Amba Användning av probiotiska bakterier för tillverkning av livsmedel eller läkemedel för förhindrande av övervikt
CN101172118A (zh) 2006-07-26 2008-05-07 美国医迈科技有限公司 作为抗传染病替代药物的益生微生物
KR20080094459A (ko) * 2007-04-20 2008-10-23 주식회사 엘지생활건강 항산화 활성을 갖는 화장료 조성물
EP2030623A1 (en) * 2007-08-17 2009-03-04 Nestec S.A. Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria
CN101130068B (zh) * 2007-09-04 2010-05-19 陈坤鑫 Sod减肥酒及其生产方法
ES2649914T3 (es) * 2007-12-26 2018-01-16 Lesaffre Et Compagnie Composición para la alimentación humana y/o animal, sus usos, levaduras
EP2241199A4 (en) * 2008-02-14 2012-08-08 Barley & Oats Co Ltd PROCESS FOR PRODUCING FERMENTED MATERIAL USING NATURAL MATERIAL AND FOOD OR MEDICINE CONTAINING THE FERMENTED MATERIAL THUS PRODUCED
US20110091553A1 (en) * 2008-06-02 2011-04-21 Kaneka Corporation Method for producing microcapsules using solid fat
JP2010100530A (ja) * 2008-10-21 2010-05-06 Ikeda Shokken Kk 抗肥満剤
WO2010083227A1 (en) * 2009-01-14 2010-07-22 Nutrafood Nutrients, Inc. Consumable dissolving film comprising active ingredients derived from bacteria and fungi
EP2216036A1 (en) 2009-02-10 2010-08-11 Nestec S.A. Lactobacillus rhamnosus NCC4007, a probiotic mixture and weight control
CN104784694A (zh) 2009-06-19 2015-07-22 杜邦营养生物科学有限公司 治疗糖尿病及相关病症的双歧杆菌
JP2011004640A (ja) * 2009-06-24 2011-01-13 Kaneka Corp 魚介エキスの精製方法
US20120121562A1 (en) * 2009-07-31 2012-05-17 Nestec S.A. Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients
IT1396074B1 (it) * 2009-10-12 2012-11-09 Axioma S R L Composizione ad attivita' termogenetica potenziata e suo impiego nella prevenzione e trattamento dell'obesita'

Also Published As

Publication number Publication date
US9555082B2 (en) 2017-01-31
SI2739295T1 (sl) 2016-04-29
EP2739295A2 (en) 2014-06-11
RS54594B1 (en) 2016-08-31
AU2012292029B2 (en) 2017-03-09
RU2600843C2 (ru) 2016-10-27
MX349242B (es) 2017-07-18
WO2013017650A2 (en) 2013-02-07
CY1117187T1 (el) 2017-04-05
UA112990C2 (uk) 2016-11-25
EP2739295B1 (en) 2015-12-30
MX2014001327A (es) 2014-02-27
GEP20166436B (en) 2016-02-25
CA2843794A1 (en) 2013-02-07
KR101954674B1 (ko) 2019-03-06
JP6126595B2 (ja) 2017-05-10
PL2739295T3 (pl) 2016-06-30
RU2014103483A (ru) 2015-08-10
ES2562647T3 (es) 2016-03-07
US20140205581A1 (en) 2014-07-24
KR20140051279A (ko) 2014-04-30
IL230723B (en) 2018-01-31
DK2739295T3 (en) 2016-03-14
SMT201600086B (it) 2016-04-29
AU2012292029A1 (en) 2014-02-20
ZA201400758B (en) 2015-10-28
ITMI20111488A1 (it) 2013-02-04
IL230723A0 (en) 2014-03-31
HUE027121T2 (en) 2016-08-29
CA2843794C (en) 2021-11-09
CN103764156A (zh) 2014-04-30
HRP20160293T1 (hr) 2016-04-22
NZ620579A (en) 2015-11-27
JP2014521343A (ja) 2014-08-28
WO2013017650A3 (en) 2013-04-04

Similar Documents

Publication Publication Date Title
IL282198A (en) Preparations containing active mitochondria and their uses
HRP20181433T1 (hr) Farmaceutski pripravak koji sadrži mio-inozitol i d-chiro-inozitol
BR112014029122A2 (pt) composições que compreendem um agente de controle biológico e um inseticida
BR112014029222A2 (pt) composições que compreendem um agente de controle biológico e um inseticida
BR112014029903A2 (pt) composições que compreendem um agente de controle biológico e um fungicida
BR112014029123A2 (pt) composições compreendendo um agente de controle biológico e um inseticida
BR112014029118A2 (pt) composições que compreendem um agente de controle biológico e um inseticida
BR112012032172A2 (pt) método para produzir um álcool e composição
DK3354665T5 (da) Modificerede alginater til celleindkapsling og celleterapi
HK1214348A1 (zh) 用於檢測維生素 的組合物和方法
BR112014004139A2 (pt) formulação; e método de controle de insetos
DK3127540T3 (da) Visse amino-pyrimidiner, sammensætninger deraf, og fremgangsmåder til deres anvendelse
BR112014029553A2 (pt) composição que compreende um agente de controle biológico e um fungicida
BR112015010947A2 (pt) composições e métodos para aumentar o metabolismo energético.
DK2678283T3 (da) Vanadiumbaserede frittematerialer og fremgangsmåder til deres fremstilling
CO6990720A2 (es) Composiciones que comprenden galatos y galamidas
BR112014029221A2 (pt) composição que compreende um agente de controle biológico e um fungicida
BR112014029689A2 (pt) composição que compreende um agente de controle biológico e um fungicida
BR112013012824A2 (pt) proteínas cry1i e genes para o controle de insetos
BR112014029224A2 (pt) composição que compreende um agente de controle biológico e um fungicida
HK1257735A1 (zh) 用於保護生物活性物質的基體和層狀組合物
BR112013014644A2 (pt) composição farmacêutica e complexo
BR112014006291A2 (pt) composição e utilização da composição
DK3144319T3 (da) Cellekultursammensætning indeholdende laminin-521
BR112012006472A2 (pt) metodo e meiso para um controle arremessavel de jogo

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08G Application fees: restoration [chapter 8.7 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL